Shanghai Unveils Massive Investment Projects and Funds to Boost High-Tech Industries
Shanghai has unleashed a flurry of policy-backed project signings and initiatives, marking a significant boost...
Policy / Regulatory
Abiomed Recalls Over 66,000 Impella Heart Pumps Due to Serious Injury Risk, FDA Classifies as Class I Event
Johnson & Johnson (J&J, NYSE: JNJ), already embroiled in lawsuits over alleged cancer risks associated...
WuXi AppTec Denies US Allegations of Unauthorized Intellectual Property Transfer
WuXi AppTec (SHA: 603259, HKG: 2359), a leading Contract Research, Development, and Manufacturing Organization (CRDMO)...
China’s National Joint Procurement Office Announces Renewal of Insulin Procurement Contracts Valued at $1.59 Billion
The National Joint Procurement Office in China has announced the renewal of drug procurement contracts...
FDA Reviews Eisai’s Leqembi for Expanded Use as Monthly Alzheimer’s Therapy
The US Food and Drug Administration (FDA) has given the green light to review an...
WuXi AppTec Denies Unauthorized IP Transfer Allegations Amidst Strong Financial Performance
WuXi AppTec (SHA: 603259, HKG: 2359), a China-based Contract Research, Development, and Manufacturing Organization (CRDMO)...
China Unveils Management Measures to Strengthen National Health Emergency Teams
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and National Disease Control...
China’s NHC Mandates Enhanced Management and Accessibility of Midwifery Services
The National Health Commission (NHC) has issued a notification with the aim of enhancing the...
NMPA Mandates Electronic Permits for Anesthetic Drugs and Psychotropic Substances
The National Medical Products Administration (NMPA) has issued a new notification aimed at enhancing the...
National Drug Sampling Inspection Report Reveals High Compliance Rates in 2023
The National Institute for Food and Drug Control (NIFDC) has released its “National Drug Sampling...
China’s National Adverse Drug Reaction Report for 2023 Highlights Stability in Reporting Trends
The National Center for ADR Monitoring has released its “National Adverse Drug Reaction Monitoring Annual...
Kobayashi Pharmaceutical Recalls Red Yeast Rice Pills in China Amid Health Concerns
Japan-based Kobayashi Pharmaceutical has reportedly initiated a product recall in the Chinese market for its...
Surprise Resignation: Congressman Gallagher Steps Down as Biosecure Act Faces Uncertainty
U.S. Congressman Mike Gallagher, the key proponent behind the recently introduced Biosecure Act aimed at...
China’s Commerce Minister Meets with Global Pharma Leaders to Discuss Innovation Cooperation
China’s Minister of Commerce, Wang Wentao, convened a high-level meeting with top executives from the...
China Unveils Action Plan to Boost Foreign Investment and Open Economy Further
The State Council of China has unveiled an ambitious “Action Plan to Promote the High-Level...
China Expands Medical Service Pricing Reform with Three Additional Pilot Provinces
The National Healthcare Security Administration (NHSA) has announced an expansion of its medical services pricing...
China’s National Joint Procurement Office Sets March 2024 for Insulin Contracts Renewal
The National Joint Procurement Office in China has released a notification outlining the information and...
CDE Seeks Public Feedback on Latest Batch of Generic Drug Reference Preparations
The Center for Drug Evaluation (CDE), a key regulatory body overseeing pharmaceutical evaluations in China,...
Legend Biotech’s Carvykti Earns FDA Committee’s Unanimous Recommendation for Expanded Use
GenScript Biotech Corporation (HKG: 1548), a Contract Research Organization (CRO) based in China, has announced...
BIO Reverses Support for WuXi AppTec Amid Security Concerns, Plans Legislative Shift
The Biotech Innovation Organization (BIO), a US-based industry lobbying group, has reversed its stance on...